Multicenter Trial of Immunologic Markers to Predict Long Term Virologic Outcomes

Toll-like Receptor 9 Agonist Treatment in Chronic HIV-1 Infection

NCT02443935 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Immune Activation Markers in HIV-infected Patients Switching to Long Acting Dual Therapy

NCT05433987 ·Status: COMPLETED

Leukapheresis to Obtain Plasma or Lymphocytes for Studies of HIV-infected Patients, Including Long-term Non-progressors

NCT00029445 ·Status: RECRUITING

Evaluating the Safety and Pharmacokinetics of VRC07-523LS in the Sera and Mucosae of Healthy, HIV-Uninfected Adult Participants

NCT03735849 ·Status: COMPLETED ·Phase: PHASE1

Combination Vaccination Before HIV Treatment Interruption

NCT00212888 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Analytical Treatment Interruption (ATI) to Assess the Immune System's Ability to Control HIV in Participants Who Became HIV-infected During the HVTN 704/HPTN 085 AMP Study

NCT04801758 ·Status: COMPLETED ·Phase: NA

Study to Optimize the Quality of Samples for Cell-mediated Immunity (CMI) in ART-naïve HIV-1-infected Subjects

NCT01610427 ·Status: COMPLETED ·Phase: NA

Qualitative and Quantitative HIV RNA Detection in Saliva Using the Oragene RNA Kit

NCT01344642 ·Status: COMPLETED

Influenza Vaccine in HIV

NCT00764998 ·Status: COMPLETED ·Phase: PHASE3

N-803 Combined With the Broadly Neutralizing Antibodies Plus or Minus haNK Cells for HIV

NCT04144335 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2

Evaluating the Safety, Tolerability, and Effect of a Human Monoclonal Antibody (VRC01) on Markers of HIV Persistence in HIV-Infected Adults Receiving Antiretroviral Therapy (ART)

NCT02411539 ·Status: COMPLETED ·Phase: PHASE1

Vaccines in a Time of Dual Pandemic: COVID-19 Vaccine in People With HIV

NCT06731127 ·Status: COMPLETED

Evaluating the Safety and Immune Response to an HIV Vaccine in Healthy, HIV-Uninfected Adults Who Have Participated in Previous HIV Vaccine Clinical Trials and in Adults Who Have Not Participated in Previous HIV Vaccine Clinical Trials

NCT01376726 ·Status: COMPLETED ·Phase: PHASE1

Near Patient Study of the OraQuick ADVANCE® HIV-1/2 Rapid Antibody Test in Oral Fluid and Fingerstick Whole Blood

NCT04810559 ·Status: COMPLETED ·Phase: NA

Resistance to HIV Infection

NCT00069485 ·Status: UNKNOWN

Early Versus Delayed Pneumococcal Vaccination in HIV

NCT00137605 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Phase I Clinical Trial To Evaluate the Toxicity, Antiviral and Immunomodulatory Effects of a Range of Doses of Ampligen in HIV-Infected Subjects

NCT00000713 ·Status: COMPLETED ·Phase: PHASE1

Immune Responses to HIV in Blood Cells in HIV-Infected and HIV-Uninfected Volunteers

NCT00027482 ·Status: COMPLETED

A Clinical Trial of PGDM1400 and PGT121 and VRC07-523LS Monoclonal Antibodies in HIV-infected and HIV-uninfected Adults

NCT03205917 ·Status: COMPLETED ·Phase: PHASE1

Immunogenicity, Safety, and Tolerability of MF59-Adjuvanted Versus Non-Adjuvanted Influenza Vaccines in Patients With HIV-1 Infection

NCT01032408 ·Status: COMPLETED ·Phase: PHASE3

Analytical Treatment Interruption (ATI) to Assess the Immune System's Ability to Control HIV in Participants Who Became HIV-infected During the HVTN 703/HPTN 081 AMP Study

NCT04860323 ·Status: COMPLETED ·Phase: NA

Pharmacokinetics and Safety of SAR441236

NCT03705169 ·Status: TERMINATED ·Phase: PHASE1

Cohort Study of Volunteers That Have Participated to Preventive HIV-1 Vaccine Trials

NCT00789789 ·Status: TERMINATED

To Evaluate Effectiveness and Safety of Containing Raltegravir in Naive HIV NON B or B Infected Patients

NCT01162538 ·Status: UNKNOWN

Bioclinical Evaluation of 2 Biomarkers of Aviremic HIV-1 in CD4+ T Cells of Adults Undergoing Treatment

NCT03940521 ·Status: ACTIVE_NOT_RECRUITING